Pathways to Better PAD Outcomes: Sirolimus DEBs and the New Treatment Algorithm

We are delighted to invite you to our training Session at CIRSE 2025: Pathways to Better PAD Outcomes: Sirolimus DEBs and the New Treatment Algorithm.

By the end of this session, participants will be able to:
 

1) Learn how to integrate DEB therapy into treatment algorithms for various PAD lesion types, from simple stenoses to complex long occlusions.                                                                                                                               

3) Compare the platform design, drug‐release kinetics, and clinical performance of SELUTION SLR™ versus paclitaxel‐based DEBs, leveraging Limus Flow evidence.

4) Apply clinical decision-making frameworks to real-world cases, fostering discussion and reflection on different treatment approaches.

We are looking forward to meeting you in Barcelona!

*Registration is open to HCPs attending CIRSE 2025

Cordis is processing your personal data in line with GDPR and limited for the purpose of the defined event. However, in case you want to receive news and updates to upcoming Cordis events for educational purposes on Cordis products and affiliated companies via email, you are able to provide consent in the next step.This consent is voluntary and can be withdrawn at any time by sending an e-mail to DPO@cordis.com.

The detailed description of the data processing as well as my rights under the GDPR at  https://cordis.com/emea/privacy-statement, in the Cordis Privacy Statement.